Sequoia Financial Advisors LLC lifted its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 6.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 365,274 shares of the industrial products company’s stock after buying an additional 21,060 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Xylem were worth $43,650,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. J. Stern & Co. LLP increased its position in Xylem by 12,326.6% during the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after purchasing an additional 45,082,435 shares in the last quarter. Norges Bank purchased a new stake in shares of Xylem in the fourth quarter valued at $361,012,000. Balyasny Asset Management L.P. increased its stake in Xylem by 346.2% in the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after purchasing an additional 553,152 shares during the last quarter. Adage Capital Partners GP L.L.C. acquired a new stake in Xylem in the 2nd quarter worth about $64,407,000. Finally, SG Americas Securities LLC grew its holdings in Xylem by 255.4% in the 1st quarter. SG Americas Securities LLC now owns 681,904 shares of the industrial products company’s stock valued at $81,488,000 after buying an additional 490,040 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
XYL has been the topic of a number of research analyst reports. UBS Group lifted their price target on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Weiss Ratings lowered shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Barclays reduced their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. Citigroup lowered their price target on Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Finally, Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $130.00 to $140.00 in a research note on Thursday, June 25th. Eight analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Xylem currently has a consensus rating of “Moderate Buy” and an average price target of $153.54.
Insiders Place Their Bets
In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jerome A. Peribere acquired 1,210 shares of Xylem stock in a transaction dated Monday, May 4th. The shares were acquired at an average price of $116.61 per share, with a total value of $141,098.10. Following the transaction, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This represents a 4.65% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 0.32% of the company’s stock.
Xylem Stock Up 2.0%
NYSE:XYL traded up $2.37 during mid-day trading on Friday, reaching $121.26. The stock had a trading volume of 1,399,557 shares, compared to its average volume of 1,783,016. The stock’s 50 day simple moving average is $112.64 and its two-hundred day simple moving average is $124.05. Xylem Inc. has a 1-year low of $105.29 and a 1-year high of $154.27. The company has a market capitalization of $28.82 billion, a price-to-earnings ratio of 30.16, a price-to-earnings-growth ratio of 1.69 and a beta of 1.03. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10.
Xylem (NYSE:XYL – Get Free Report) last posted its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.09 by $0.03. The business had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Equities analysts anticipate that Xylem Inc. will post 5.51 EPS for the current year.
Xylem Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio is 42.79%.
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
